Metabolomics and lipidomics can identify substrate stress, mitochondrial bottlenecks, amino acid imbalance, redox dysregulation, and systemic drivers such as diabetes or chronic kidney disease ( This review synthesizes recent evidence on key metabolic derangementssubstrate inflexibility, mitochondrial dysfunction, BCAA accumulation, and ketone adaptationin myocardial hypertrophy, and critically examines their potential as clinically interpretable biomarker modules and therapeutic targets, while highlighting the persistent challenges in distinguishing adaptive from maladaptive remodeling and translating pathway signals into practice
The mechanism of action of GHK-Cu is based on several interconnected signaling pathways
doi: 10.17219/pim/189406 58 HungCMTsaiTHLeeKTHsuYC
Research suggests that it sequesters activin A and myostatin, reduces SMAD2/3 signaling, and, in preclinical models, has been used to investigate skeletal muscle biology, liver fibrosis, and tumor behavior
Frequently Asked Questions Glossary of Terms References Seiwerth S, et al